{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-002048","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2024-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.950228+00:00","generated_at":"2026-06-07T00:34:28.441645+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sigyn Therapeutics enters share surrender agreement with CTO to cancel 2.56M shares","bullets":["Craig Roberts, CTO and board member, surrenders 2,564,000 shares of common stock for cancellation.","Shares are cancelled and not held as treasury shares; no further claims against the company.","As of Jan 9, 2024, total outstanding shares are 48,972,602 following this surrender and note conversions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-002048","json":"https://secwatch.observer/filing/0001493152-24-002048.json","markdown":"https://secwatch.observer/filing/0001493152-24-002048.md","text":"https://secwatch.observer/filing/0001493152-24-002048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224002048/0001493152-24-002048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224002048/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T00:34:28.441645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d632f72bd47028da4eda0119be002a476a6a7a33","claim":"Sigyn Therapeutics, Inc. entered into Share Surrender Agreement with Craig Roberts (effective 2024-01-09).","evidence_excerpt":"On January 9, 2024, Sigyn Therapeutics, Inc. (the “Company”) entered into a Share Surrender Agreement with Craig Roberts, Chief Technical Officer and member of the board of directors of the Company (the “Shareholder”), whereas the parties agreed that 2,564,000 shares of common stock, par value $0.001, shall be surrendered by the Shareholder to the Company for cancellation and shall subsequently not be held as treasury shares or represent any claim against the Company whatsoever, effective immediately.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224002048/0001493152-24-002048-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Craig Roberts"},{"label":"Effective","value":"2024-01-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}